NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 138 filers reported holding NEOGENOMICS INC in Q3 2016. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,330 | +17.9% | 421 | -37.4% | 0.00% | 0.0% |
| Q4 2022 | $6,219 | +107.3% | 673 | +71.2% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 393 | +214.4% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | -77.8% | 125 | -66.9% | 0.00% | -66.7% |
| Q3 2021 | $18,000 | +80.0% | 378 | +79.1% | 0.00% | +50.0% |
| Q2 2021 | $10,000 | -23.1% | 211 | -23.0% | 0.00% | -66.7% |
| Q1 2021 | $13,000 | +62.5% | 274 | +80.3% | 0.01% | +50.0% |
| Q4 2020 | $8,000 | +33.3% | 152 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $6,000 | +20.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $5,000 | +25.0% | 152 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $4,000 | +100.0% | 152 | +117.1% | 0.00% | +100.0% |
| Q4 2019 | $2,000 | 0.0% | 70 | -39.1% | 0.00% | 0.0% |
| Q3 2019 | $2,000 | 0.0% | 115 | +64.3% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | +100.0% | 70 | +32.1% | 0.00% | – |
| Q1 2019 | $1,000 | – | 53 | -10.2% | 0.00% | – |
| Q3 2016 | $0 | – | 59 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 59 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,614,263 | $19,613,000 | 10.60% |
| Samjo Capital LLC | 185,000 | $2,248,000 | 1.92% |
| PERKINS CAPITAL MANAGEMENT INC | 152,550 | $1,853,000 | 1.52% |
| Cowen Prime Advisors LLC | 183,500 | $2,230,000 | 0.94% |
| First Light Asset Management, LLC | 805,958 | $9,792,000 | 0.86% |
| Soleus Capital Management, L.P. | 460,000 | $5,589,000 | 0.72% |
| Greenhouse Funds LLLP | 574,956 | $6,986,000 | 0.70% |
| Bullseye Asset Management LLC | 108,054 | $1,313,000 | 0.60% |
| Ranger Investment Management | 776,428 | $9,434,000 | 0.60% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 960,832 | $11,674,000 | 0.52% |